Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.9 USD | -1.85% | -2.40% | -12.10% |
07/05 | Transcript : Viemed Healthcare, Inc., Q1 2024 Earnings Call, May 07, 2024 | |
06/05 | Earnings Flash (VMD) VIEMED HEALTHCARE Reports Q1 Revenue $50.6M | MT |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
- The company has a poor ESG score according to Refinitiv, which ranks companies by sector.
Strengths
- Growth is a substantial asset for the company, as anticipated by dedicated analysts. Within the next three years, growth is estimated to reach -99% by 2026.
- The company's profit outlook over the next few years is a strong asset.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
Weaknesses
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-12.10% | 273M | C- | ||
+16.49% | 83.4B | C+ | ||
-29.52% | 72.11B | B- | ||
0.00% | 27.04B | C+ | ||
-13.29% | 16.96B | B | ||
+1.03% | 16.86B | A- | ||
+1.57% | 15.76B | A- | ||
+71.63% | 13.33B | C- | ||
+1.53% | 12.76B | B- | ||
+70.68% | 12.74B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
- Stock Market
- Equities
- VMD Stock
- Ratings Viemed Healthcare, Inc.